Evaluating the cognitive effects of donepezil 23 mg/d in moderate and severe Alzheimer’s disease: analysis of effects of baseline features on treatment response

BACKGROUND: Treatment of Alzheimer’s disease with acetylcholinesterase inhibitors can result in symptomatic benefits, but patients often show variable responses. The objective of this post hoc analysis was to investigate relationships between easily identifiable baseline characteristics/demographics...

Descripción completa

Detalles Bibliográficos
Autores principales: Sabbagh, Marwan, Cummings, Jeffrey, Christensen, Daniel, Doody, Rachelle, Farlow, Martin, Liu, Liang, Mackell, Joan, Fain, Randi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3681558/
https://www.ncbi.nlm.nih.gov/pubmed/23742728
http://dx.doi.org/10.1186/1471-2318-13-56

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3681558/
https://www.ncbi.nlm.nih.gov/pubmed/23742728
http://dx.doi.org/10.1186/1471-2318-13-56

Ejemplares similares